Jean Lemoine

This inventor holds 5 USPTO granted patents. Top assignees: Laboratoire Debat, Institut De Recherches Chimiques Et Biologiques Appliquees, Laboratories Debat. Active years: 1979-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Lemoine. Retrieved from https://idiyas.com/inventor/jean-lemoine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

Institut De Recherches Chimiques Et Biologiques Appliquees

Societe Anonyme Dite: Laboratoire Debat

patent

Years Active: 1979-1984

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4485111 - Derivatives of 3-amino-1-benzofuranyloxy-2-propanol useful as (1984-11-27),

2. 4263285 - Globularia extract, its method of preparation and its use as (1981-04-21),

3. 4254112 - Inula extract, its method of preparation and its use as pharmaceutical (1981-03-03),

4. 4235890 - Stephania cepharantha extract, its method of preparation and its use as (1980-11-25),

5. 4151278 - Process for the preparation of an extract of Teucrium marum used in (1979-04-24),

Title: The Innovative Contributions of Jean Lemoine

Introduction

Jean Lemoine is a notable inventor based in Garches, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 5 patents to his name, Lemoine's work has had a considerable impact on medical science.

Latest Patents

Lemoine's latest patents include innovative compounds that serve important therapeutic functions. One of his notable inventions is related to derivatives of 3-amino-1-benzofuranyloxy-2-propanol, which are useful as cardioselective beta-blocking agents. This invention presents new industrial products, specifically the compounds of general formula: ##STR1## where R is CH(CH.sub.3).sub.2 or C(CH.sub.3).sub.3, along with their acid addition salts. Another significant patent involves an extract from the Globularia genus, such as Globularia alypum and Globularia vulgaris. This extract is recognized for its antibrucella, bacteriostatic, and antiphlogistic properties, making it valuable in both human and veterinary therapy, particularly for treating brucellosis.

Career Highlights

Throughout his career, Lemoine has worked with reputable companies, including Laboratoire Debat and Société Anonyme Dite: Laboratoire Debat. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic solutions.

Collaborations

Lemoine has collaborated with several professionals in his field, including Jacques Debat and Françoise Lier Nee Gabillault. These collaborations have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

Jean Lemoine's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence therapeutic practices and improve patient care.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]